… of glaucoma is a common complication among patients diagnosed with Fuchs’ endothelial
dystrophy (FED) after treatment … glaucoma rates and ophthalmic steroid use in FED patients …

… history of the patient’s respiratory symptoms, … treatment like inhaled bronchodilators and/or
inhaled corticosteroids and/ or systemic glucocorticoid therapy, compliance with the treatment …

… bronchodilators for patients with asthma, regardless of age. Their main therapeutic action
is … the elderly population where the prevalence of prostatic diseases and glaucoma is high[23]. …

… the patient with normal intraocular physiology, this increase in pressure may be very significant
for patients with glaucoma or … mines, steroids, or inhaled bronchodilators are not effective. …

… patients with a change in vision or with a history of increased intraocular pressure, glaucoma…
in conjunction with nebulizer-based inhaled therapy for bronchodilator therapy, because the …

… We have studied eyes that underwent trabeculectomy for glaucoma or uncontrollable ocular
hypertension with topical medication following vitrectomy and found that 60% of the eyes …

… flow is likely to enhance the action of inhaled bronchodilators by diminishing their clearance
from the … administration of ICS and bronchodilators is likely to be of clinical significance [11]. …

… A nebulized solution of 2.5 mg two or three times a day as needed is acceptable for quick …
Adverse Effects The primary adverse effects of albuterol therapy are tremors and nervousness, …

… , development of glaucoma, elevated intraocular pressure purpura and skin thinning [158]. …
is focused on inhaled bronchodilators. The use of short-acting bronchodilators is prescribed …

… glaucoma or raised intra-ocular pressure requiring treatment. … effect of ICSs on the risk of
glaucoma or raised intra-ocular … inhaled triple therapy versus dual bronchodilator therapy in …